275 related articles for article (PubMed ID: 24465612)
1. Grey matter changes in cognitively impaired Parkinson's disease patients.
Rektorova I; Biundo R; Marecek R; Weis L; Aarsland D; Antonini A
PLoS One; 2014; 9(1):e85595. PubMed ID: 24465612
[TBL] [Abstract][Full Text] [Related]
2. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
4. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
5. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
[TBL] [Abstract][Full Text] [Related]
6. Neurodegeneration across stages of cognitive decline in Parkinson disease.
Weintraub D; Doshi J; Koka D; Davatzikos C; Siderowf AD; Duda JE; Wolk DA; Moberg PJ; Xie SX; Clark CM
Arch Neurol; 2011 Dec; 68(12):1562-8. PubMed ID: 22159053
[TBL] [Abstract][Full Text] [Related]
7. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
[TBL] [Abstract][Full Text] [Related]
8. Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease.
Stojkovic T; Stefanova E; Soldatovic I; Markovic V; Stankovic I; Petrovic I; Agosta F; Galantucci S; Filippi M; Kostic V
J Neurol; 2018 Jun; 265(6):1320-1327. PubMed ID: 29572571
[TBL] [Abstract][Full Text] [Related]
9. Neural correlates of attentional deficits in Parkinson's disease patients with mild cognitive impairment.
Yang J; Pourzinal D; McMahon KL; Byrne GJ; Copland DA; O'Sullivan JD; Dissanayaka NN
Parkinsonism Relat Disord; 2021 Apr; 85():17-22. PubMed ID: 33647838
[TBL] [Abstract][Full Text] [Related]
10. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
11. Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality.
Danti S; Toschi N; Diciotti S; Tessa C; Poletti M; Del Dotto P; Lucetti C
Eur J Neurol; 2015 Dec; 22(12):1564-72. PubMed ID: 26212370
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal Progression Patterns of Dopamine Availability and Deep Gray Matter Volume in Parkinson Disease-Related Cognitive Impairment.
Oh Y; Kim JS; Lyoo CH; Park G; Kim H
Neurology; 2024 Jul; 103(2):e209498. PubMed ID: 38885485
[TBL] [Abstract][Full Text] [Related]
13. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
[TBL] [Abstract][Full Text] [Related]
14. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
[TBL] [Abstract][Full Text] [Related]
15. Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.
Mak E; Zhou J; Tan LC; Au WL; Sitoh YY; Kandiah N
J Neurol Neurosurg Psychiatry; 2014 May; 85(5):576-80. PubMed ID: 24133286
[TBL] [Abstract][Full Text] [Related]
16. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
17. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
18. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
Xu Y; Yang J; Hu X; Shang H
J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
[TBL] [Abstract][Full Text] [Related]
19. Functional and structural changes in gray matter of parkinson's disease patients with mild cognitive impairment.
Chen B; Wang S; Sun W; Shang X; Liu H; Liu G; Gao J; Fan G
Eur J Radiol; 2017 Aug; 93():16-23. PubMed ID: 28668411
[TBL] [Abstract][Full Text] [Related]
20. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
